Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.55M
3K shares
What this filing means
WAGNER CHARLES F JR plans to sell 3K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2024ACC: 0001959173-24-007638
Officer· EVP and CFO
Since Apr 2019
3K
Shares to sell
$1.55M
Approx. market value
3K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months7
ESPP Purchase
Cash
5/14/2023
63.00Restricted Stock Vesting
Compensation
2/24/2023
1.76KRestricted Stock Vesting
Compensation
2/17/2023
256.00ESPP Purchase
Cash
11/14/2022
38.00ESPP Purchase
Cash
5/14/2022
96.00Restricted Stock Vesting
Compensation
2/24/2022
769.00ESPP Purchase
Cash
11/14/2021
14.00Total acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2023 | ESPP Purchase Cash | 63.00 | — |
2/24/2023 | Restricted Stock Vesting Compensation | 1.76K | — |
2/17/2023 | Restricted Stock Vesting Compensation | 256.00 | — |
11/14/2022 | ESPP Purchase Cash | 38.00 | — |
5/14/2022 | ESPP Purchase Cash | 96.00 | — |
2/24/2022 | Restricted Stock Vesting Compensation | 769.00 | — |
11/14/2021 | ESPP Purchase Cash | 14.00 | — |
| Total | 3K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3K
Market value
$1.55M
11/11/2024
Total
Units
3K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/11/2024 | 3K | $1.55M | NASDAQ | Planned |
| Total | 3K | $1.55M | ||